Valuation: Tong Ren Tang Technologies Co. Ltd.

Market Cap 3.61B 4.21B 537M 460M 431M 394M 740M 51.42B 750M 5.09B 1.98B 25.83B 2.02B 1.97B 85.44B P/E 2026 *
7.95x
P/E 2027 * 7.05x
Enterprise Value 3.61B 4.21B 537M 460M 431M 394M 740M 51.42B 750M 5.09B 1.98B 25.83B 2.02B 1.97B 85.44B EV / Sales 2026 *
0.52x
EV / Sales 2027 * 0.48x
Free-Float
45.7%
Yield 2026 *
5.67%
Yield 2027 * 6.38%
09/07 Tong Ren Tang Technologies Co. Ltd. Announces Executive Changes, Effective July 9, 2026 CI
29/06 Tong Ren Tang Chinese Medicine Enters Product Sales Contract with Tong Ren Tang Technologies MT
29/06 Beijing Tong Ren Tang Chinese Medicine Company Limited and Tong Ren Tang Technologies Co. Ltd. Enter Product Sales Framework Agreement CI
12/06 Tong Ren Tang Technologies Co. Ltd. Approves Final Dividend for the Year Ended 31 December 2025, Payable on 11 August 2026 CI
26/05 Tong Ren Tang Technologies receives certificate of registration for antelope horn powder capsules in Hong Kong RE
27/04 Tong Ren Tang Technologies Logs 169 Million Yuan in Q1 Profit MT
30/03 Tong Ren Tang's Profit Slides 24% in 2025; Shares Slip 3% MT
27/03 Tong Ren Tang Technologies Co. Ltd. Proposes Final Dividend for the Year Ended December 31, 2025, Payable on August 11, 2026 CI
27/03 Tong Ren Tang Technologies Co. Ltd. Reports Earnings Results for the Full Year Ended December 31, 2025 CI
27/03 Tong Ren Tang Technologies Co. Ltd. announces Annual dividend, payable on August 11, 2026 CI
06/02 Tong Ren Tang Technologies Co. Ltd. Announces Appointment of Mr. Siu, Paul Yu Hay as Independent Non-Executive Director and Changes in Board Committee Composition, Effective February 6, 2026 CI
13/01 Tong Ren Tang Technologies Co. Ltd. Announces Resignation of Li Siu Bun from the Positions as an Independent Non-Executive Director, Chairman of the Audit Committee of the Board and A Member of Each of the Remuneration Committee of the Board and the Strategy and Planning Committee CI
31/12 Tong Ren Tang Technologies Co. Ltd. Announces Board Changes CI
1 day-3.80%
1 week-2.91%
Current month-10.09%
1 month-7.99%
3 months-11.84%
6 months-28.07%
Current year-28.23%
1 week 3.14
Extreme 3.14
3.38
1 month 3.14
Extreme 3.14
3.59
Current year 3.07
Extreme 3.07
4.56
1 year 3.07
Extreme 3.07
5.38
3 years 3.07
Extreme 3.07
7.03
5 years 3.07
Extreme 3.07
9.28
10 years 3.07
Extreme 3.07
16
Manager TitleAgeSince
Chief Executive Officer 58 04/06/2025
Comptroller/Controller/Auditor 48 04/06/2025
Corporate Secretary 43 28/11/2025
Director TitleAgeSince
Director/Board Member 69 12/06/2018
Director/Board Member 66 06/02/2026
Director/Board Member 82 12/06/2018
Change 5-day change 1-year change 3-year change Capi.($)
-3.34%-2.91%-41.17%-49.60% 537M
-1.75%-1.40%-14.42%-5.80% 13.09B
-2.74%-2.90%-35.91%-58.08% 4.85B
-6.30%-6.88%-7.32%-6.01% 4.59B
-5.35%-3.01%+1.29%-26.92% 4.09B
-2.56%-2.27%-24.04%+2.40% 3.51B
-2.87%-0.49%-11.37%-6.48% 3.34B
-3.23%-2.35%-12.30%+13.41% 3.33B
-4.14%-2.45%-18.19%-14.63% 2.43B
-3.92%-3.50%-30.34%-13.28% 1.67B
Average -3.67%-2.40%-19.38%-16.50% 4.14B
Weighted average by Cap. -3.26%-2.31%-16.21%-13.23%

Financials

2026 *2027 *
Net sales 6.98B 8.14B 1.04B 890M 832M 762M 1.43B 99.37B 1.45B 9.84B 3.84B 49.92B 3.9B 3.82B 165B 7.56B 8.82B 1.13B 964M 902M 825M 1.55B 108B 1.57B 10.65B 4.15B 54.07B 4.22B 4.13B 179B
Net income 454M 530M 67.61M 57.91M 54.19M 49.6M 93.09M 6.47B 94.32M 640M 250M 3.25B 254M 248M 10.75B 514M 599M 76.39M 65.43M 61.22M 56.04M 105M 7.31B 107M 723M 282M 3.67B 287M 281M 12.14B
Net Debt - -
Logo Tong Ren Tang Technologies Co. Ltd.
Tong Ren Tang Technologies Co Ltd is a China-based company principally engaged in the production and distribution of Chinese medicine. The Company primarily operates its businesses through two segments. The Company segment is mainly engaged in the manufacture and sale of Chinese medicine. Tong Ren Tang Chinese Medicine segment is mainly involved in manufacturing, retail and wholesale of Chinese medicine products and healthcare products, and provision of Chinese medical consultation and treatments services. The Company is also engaged in processing and purchasing of Chinese medicinal raw materials, sales of medicinal products, medical services and advertising business. The Company mainly conducts its businesses in the domestic market.
Employees
3,951
Date Price Change Volume
24/08/26 HKD 3.180 -3.34% 494,000
21/08/26 HKD 3.290 -0.90% 2,486,000
20/08/26 HKD 3.320 +1.84% 1,899,000
19/08/26 HKD 3.260 +0.93% 1,500,000
18/08/26 HKD 3.230 -0.92% 1,313,000
Trader
Investor
Global
Quality
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
2.821CNY
Average target price
4.601CNY
Spread / Average Target
+63.10%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 1666 Stock